Defibrotide Inhibits Antiphospholipid Antibody–Mediated Neutrophil Extracellular Trap Formation and Venous Thrombosis
dc.contributor.author | Ali, Ramadan A. | |
dc.contributor.author | Estes, Shanea K. | |
dc.contributor.author | Gandhi, Alex A. | |
dc.contributor.author | Yalavarthi, Srilakshmi | |
dc.contributor.author | Hoy, Claire K. | |
dc.contributor.author | Shi, Hui | |
dc.contributor.author | Zuo, Yu | |
dc.contributor.author | Erkan, Doruk | |
dc.contributor.author | Knight, Jason S. | |
dc.date.accessioned | 2022-05-06T17:30:43Z | |
dc.date.available | 2023-06-06 13:30:40 | en |
dc.date.available | 2022-05-06T17:30:43Z | |
dc.date.issued | 2022-05 | |
dc.identifier.citation | Ali, Ramadan A.; Estes, Shanea K.; Gandhi, Alex A.; Yalavarthi, Srilakshmi; Hoy, Claire K.; Shi, Hui; Zuo, Yu; Erkan, Doruk; Knight, Jason S. (2022). "Defibrotide Inhibits Antiphospholipid Antibody–Mediated Neutrophil Extracellular Trap Formation and Venous Thrombosis." Arthritis & Rheumatology 74(5): 902-907. | |
dc.identifier.issn | 2326-5191 | |
dc.identifier.issn | 2326-5205 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/172357 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Defibrotide Inhibits Antiphospholipid Antibody–Mediated Neutrophil Extracellular Trap Formation and Venous Thrombosis | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Rheumatology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172357/1/art42017_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172357/2/art42017.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172357/3/art42017-sup-0001-Disclosureform.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/172357/4/art42017-sup-0001-Figures.pdf | |
dc.identifier.doi | 10.1002/art.42017 | |
dc.identifier.source | Arthritis & Rheumatology | |
dc.identifier.citedreference | Ho VT, Revta C, Richardson PG. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies [review]. Bone Marrow Transplant 2008; 41: 229 – 37. | |
dc.identifier.citedreference | Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R, et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev 2014; 13: 917 – 30. | |
dc.identifier.citedreference | Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532 – 5. | |
dc.identifier.citedreference | Kenny EF, Herzig A, Kruger R, Muth A, Mondal S, Thompson PR, et al. Diverse stimuli engage different neutrophil extracellular trap pathways. Elife 2017; 6. | |
dc.identifier.citedreference | Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012; 7: e32366. | |
dc.identifier.citedreference | Grenn RC, Yalavarthi S, Gandhi AA, Kazzaz NM, Nunez-Alvarez C, Hernandez-Ramirez D, et al. Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome. Ann Rheum Dis 2017; 76: 450 – 7. | |
dc.identifier.citedreference | Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010; 107: 15880 – 5. | |
dc.identifier.citedreference | Yalavarthi S, Gould TJ, Rao AN, Mazza LF, Morris AE, Núñez-Álvarez C, et al. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol 2015; 67: 2990 – 3003. | |
dc.identifier.citedreference | Meng H, Yalavarthi S, Kanthi Y, Mazza LF, Elfline MA, Luke CE, et al. In vivo role of neutrophil extracellular traps in antiphospholipid antibody–mediated venous thrombosis. Arthritis Rheumatol 2017; 69: 655 – 67. | |
dc.identifier.citedreference | Ali RA, Gandhi AA, Meng H, Yalavarthi S, Vreede AP, Estes SK, et al. Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome. Nat Commun 2019; 10: 1916. | |
dc.identifier.citedreference | Ali RA, Gandhi AA, Dai L, Weiner J, Estes SK, Yalavarthi S, et al. Antineutrophil properties of natural gingerols in models of lupus. JCI Insight 2021; 6. | |
dc.identifier.citedreference | Sule G, Kelley WJ, Gockman K, Yalavarthi S, Vreede AP, Banka AL, et al. Increased adhesive potential of antiphospholipid syndrome neutrophils mediated by β2 integrin mac-1. Arthritis Rheumatol 2020; 72: 114 – 24. | |
dc.identifier.citedreference | Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D, et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737 – 44. | |
dc.identifier.citedreference | Pescador R, Capuzzi L, Mantovani M, Fulgenzi A, Ferrero ME. Defibrotide: properties and clinical use of an old/new drug. Vascul Pharmacol 2013; 59: 1 – 10. | |
dc.identifier.citedreference | Di Perri T, Pasini FL, Capecchi PL, Ceccatelli L, Pasqui AL, Orrico A. Defibrotide in vitro inhibits neutrophil activation by a Ca++-involving mechanism. Int J Tissue React 1987; 9: 399 – 406. | |
dc.identifier.citedreference | Burcoglu-O’Ral A, Erkan D, Asherson R. Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator. J Rheumatol 2002; 29: 2006 – 11. | |
dc.identifier.citedreference | Bianchi G, Calvani AB, Mantovani M, Prino G. Enhancement by defibrotide of prostanoid neosynthesis from arachidonic acid: an adenosine receptor-mediated effect? Semin Thromb Hemost 1991; 17: 399 – 403. | |
dc.identifier.citedreference | Bianchi G, Barone D, Lanzarotti E, Tettamanti R, Porta R, Moltrasio D, et al. Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist. Eur J Pharmacol 1993; 238: 327 – 34. | |
dc.identifier.citedreference | Pasini FL, Frigerio C, Capecchi PL, Ceccatelli L, Messa GL, Franchi M, et al. Modulation of venous endothelial activity and transcellular calcium transport by defibrotide: the adenosine hypothesis. Semin Thromb Hemost 1996; 22 Suppl: 15 – 20. | |
dc.identifier.citedreference | Van der Hoeven D, Wan TC, Auchampach JA. Activation of the A adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils. Mol Pharmacol 2008; 74: 685 – 96. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.